Cargando…
Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma
BACKGROUND: The aim of this study was to clarify the role of global hypomethylation of repetitive elements in determining the genetic and clinical features of multiple myeloma (MM). METHODS: We assessed global methylation levels using four repetitive elements (long interspersed nuclear element-1 (LI...
Autores principales: | Aoki, Yuka, Nojima, Masanori, Suzuki, Hiromu, Yasui, Hiroshi, Maruyama, Reo, Yamamoto, Eiichiro, Ashida, Masami, Itagaki, Mitsuhiro, Asaoku, Hideki, Ikeda, Hiroshi, Hayashi, Toshiaki, Imai, Kohzoh, Mori, Mitsuru, Tokino, Takashi, Ishida, Tadao, Toyota, Minoru, Shinomura, Yasuhisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064317/ https://www.ncbi.nlm.nih.gov/pubmed/23259664 http://dx.doi.org/10.1186/gm402 |
Ejemplares similares
-
Correction: Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma
por: Aoki, Yuka, et al.
Publicado: (2013) -
Model of translational cancer research in multiple myeloma
por: Yasui, Hiroshi, et al.
Publicado: (2012) -
A genomic screen for long noncoding RNA genes epigenetically silenced by aberrant DNA methylation in colorectal cancer
por: Kumegawa, Kohei, et al.
Publicado: (2016) -
Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer
por: Maruyama, Reo, et al.
Publicado: (2008) -
Interferon-α/β and Anti-Fibroblast Growth Factor Receptor 1 Monoclonal Antibody Suppress Hepatic Cancer Cells In Vitro and In Vivo
por: Sasaki, Shigeru, et al.
Publicado: (2011)